| Medical Physiology | Lifetime | 23 | AU 2 | 99.97 |
| Molecular Biology | Lifetime | 638 | AU 6 | 99.68 |
| Psychiatry and Mental health | Lifetime | 276 | AU 22 | 99.14 |
| Neuroscience of Neurology | Lifetime | 406 | AU 21 | 96.85 |
| Nutrition and Dietetics | Lifetime | 795 | AU 34 | 96.18 |
| Clinical Neurology | Lifetime | 707 | AU 23 | 96.35 |
| Medical Physiology | 2021-2025 | 41 | AU 2 | 99.43 |
| Psychiatry and Mental health | 2021-2025 | 76 | AU 8 | 98.90 |
| Clinical Neurology | 2021-2025 | 468 | AU 10 | 82.77 |
| Neuroscience of Neurology | 2021-2025 | 298 | AU 18 | 78.63 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 921 | AU 32 | 75.63 |
| Prion Diseases and Protein Misfolding | Lifetime | 3 | AU 1 | 99.88 |
| Alzheimer's disease research and treatments | Lifetime | 17 | AU 1 | 99.96 |
| Cholinesterase and Neurodegenerative Diseases | Lifetime | 17 | AU 1 | 99.76 |
| Computational Drug Discovery Methods | Lifetime | 40 | AU 1 | 99.54 |
| Trace Elements in Health | Lifetime | 38 | AU 3 | 99.49 |
| Dementia and Cognitive Impairment Research | Lifetime | 62 | AU 4 | 99.76 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 50 | AU 1 | 99.10 |
| Neurological diseases and metabolism | Lifetime | 62 | AU 2 | 99.14 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 801 | AU 19 | 97.51 |
| Nuclear Receptors and Signaling | Lifetime | 187 | AU 3 | 97.07 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 351 | AU 8 | 97.15 |
| S100 Proteins and Annexins | Lifetime | 459 | AU 17 | 95.75 |
| RNA regulation and disease | Lifetime | 703 | AU 12 | 94.92 |
| Amyotrophic Lateral Sclerosis Research | Lifetime | 701 | AU 42 | 93.36 |
| Health, Environment, Cognitive Aging | Lifetime | 746 | AU 27 | 91.65 |
| Alcoholism and Thiamine Deficiency | Lifetime | 691 | AU 29 | 87.54 |
| Aluminum toxicity and tolerance in plants and animals | Lifetime | 953 | AU 53 | 88.52 |
| Cognitive Functions and Memory | Lifetime | 749 | AU 48 | 78.02 |
| Clusterin in disease pathology | Lifetime | 509 | AU 24 | 61.60 |
| Alzheimer's disease research and treatments | 2021-2025 | 35 | AU 1 | 99.60 |
| Dementia and Cognitive Impairment Research | 2021-2025 | 59 | AU 3 | 99.38 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 323 | AU 6 | 94.49 |
| Health, Environment, Cognitive Aging | 2021-2025 | 342 | AU 2 | 88.61 |
| S100 Proteins and Annexins | 2021-2025 | 201 | AU 5 | 81.86 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 442 | AU 14 | 82.66 |
| Prion Diseases and Protein Misfolding | 2021-2025 | 184 | AU 1 | 82.05 |
| Nuclear Receptors and Signaling | 2021-2025 | 214 | AU 4 | 75.51 |
| Ginkgo biloba and Cashew Applications | 2021-2025 | 479 | AU 5 | 51.86 |
